FLUOROSCOPY AND C-ARM MARKET ANALYSIS

Fluoroscopy and C-Arm Market Size and Trends

The global fluoroscopy and C-Arm market is estimated to be valued at USD 4.10 Bn in 2024 and is expected to reach USD 5.71 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.

Key Takeaways of the Fluoroscopy and C-Arm Market:

• By type, the C-Arms segment is expected to contribute the highest share of the market with 52.1% in 2024
• By application, the cardiology segment is expected to contribute the highest share of the market with 23.1% in 2024
• By portability, the fixed systems segment is expected to contribute the highest share of the market with 51.1% in 2024
• North America is expected to top the global market with 37.3% share, followed by Asia Pacific with 25.2% share in 2024

Market Overview:

Advancements in medical imaging technologies and rising chronic disease prevalence are fueling demand for these devices globally. The rising elderly population and increasing road accidents and trauma cases also drive market revenue. The market is witnessing growing demand for fully-motorized C-arms as they provide better image quality and higher versatility compared to traditional C-arms. Features like flat panel detectors and high resolution are gaining popularity. Furthermore, the increasing consolidation among market players to improve product portfolio through mergers and acquisitions will define the competitive dynamics over the coming years.

To learn more about this report, Request sample copy

Key Developments:

• In November 2024, GE HealthCare, a global medical technology, introduced advanced imaging innovations for its OEC 3D mobile CBCT C-arm, enhancing precision and workflow in interventional pulmonology. The addition of the Lung Suite and expanded third-party data interface options streamline imaging during endoscopic bronchoscopy procedures, helping clinicians accurately locate and biopsy lung nodules despite challenges like respiratory pattern changes and CT-to-body divergence. These advancements aim to improve diagnostic confidence and efficiency in complex pulmonary and thoracic procedures.
• In November 2024, Augmedics, a developer of an augmented-reality surgical visualization system, announced the USFDA 510(k) clearance for its new CT-to-fluoroscopy (CT-Fluoro) registration method for the xvision Spine System, enabling AR navigation with preoperative CT scans and standard 2D C-arm images, eliminating the need for 3D intraoperative imaging. The first surgery using this method was successfully performed by Dr. Frank Phillips at Rush University Medical Center, highlighting its potential to expand AR navigation access for spine surgeons.
• In March 2024, Siemens Healthineers has received U.S. FDA clearance for the CIARTIC Move, a self-driving mobile C-arm that streamlines 2D fluoroscopic and 3D cone-beam CT imaging for surgeries. Designed for orthopedic, trauma, spine, and other procedures, it automates workflows, reduces imaging time, and supports overtaxed operating room teams. This innovation marks Siemens’ first self-driving mobile C-arm, enhancing efficiency in hospitals and outpatient facilities.
• In July 2022, FUJIFILM Healthcare Americas Corporation, a leading innovator in diagnostic and enterprise imaging solutions, launched the Flat Detector Radiography,FDR Cross in the U.S., an innovative hybrid C-arm and portable X-ray system designed for hospitals and ambulatory surgery centers. This dual-function system combines fluoroscopic and radiographic imaging on a single platform, streamlining workflows and improving patient care. According to Rob Fabrizio, the FDR Cross enhances equipment efficiency by enabling multiple imaging functions with one device.

Top Strategies Followed by global fluoroscopy and C-Arm market Players

• Established Players: Leading companies such as Siemens and GE Healthcare prioritize extensive research and development to innovate high-performance products.
  • For Instance, in December 2024, Siemens launched a new fluoroscopy system that incorporates advanced imaging technology, enhancing diagnostic accuracy and patient outcomes. This investment in R&D underscores its commitment to maintaining a competitive edge in the market.
• Mid-Level Players: Mid-level players focus on delivering quality, budget-friendly products targeting price-sensitive consumers.
  • For instance, in August 2022, Xoran Technologies received U.S. FDA 510(k) clearance for TRON, a mobile full-body fluoroscopy and CT X-ray system. Designed for compact settings like operating rooms and critical care units, TRON offers secure, ultra-high-resolution, low-dose imaging.
• Small-Scale Players: Small players leverage niche specialization to carve out space. Brainlab developed ExacTrac, a niche image-guided radiotherapy platform optimized for precise oncology treatments. Ziehm Imaging focuses on mobile C-arm solutions for use in surgery rooms, allowing freedom of movement during procedures.

Emerging Startups - Fluoroscopy and C-Arm Industry Ecosystem

• Innovative Technologies: Startups are exploring advanced technologies like Anthropic’s surgical vision system using AI to enhance surgical imaging. Boundary Layer uses smart sensor fusion for robotic precision and 3D imaging in its Explorer C-arm, improving operating room workflows.
• Sustainable Solutions: Echo360 Sustainable Imaging produces zero-waste desktop fluoroscopy machines made from recycled ocean plastics and electronic waste. Ambient Medical develops reusable, non-disposable covers and drapes made from rapidly renewable bamboo fiber, lowering environmental impact.
• Market Contribution: Startups often address underserved market areas. Peak Surgical developed the MolecuLight i:X, a handheld fluorescence imaging device for detecting bacteria in wounds, opening new clinical applications. Startups address unique market needs by developing specialized C-arm systems for specific procedures, such as orthopedic or dental surgeries.